Clinical Trial Update: Trans-catheter Arterial Embolization Combined With p53 Gene Therapy for Treatment of Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating trans-catheter arterial embolization combined with p53 gene therapy for advanced hepatocellular carcinoma; sponsor Shenzhen Si…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• p53 gene therapy (p53 gene therapy)

Snippet

Sponsor: Shenzhen SiBiono GeneTech Co.,Ltd | Conditions: Advanced Hepatocellular Carcinoma (HCC) | Phase 2 | Status: UNKNOWN